Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by mollevi
Last modified by alainmange
Group name PlateformePP2I
Item Type Journal Article
Title PIP30/FAM192A is a novel regulator of the nuclear proteasome activator PA28?
Creator Jonik-Nowak et al.
Author Beata Jonik-Nowak
Author Thomas Menneteau
Author Didier Fesquet
Author Véronique Baldin
Author Catherine Bonne-Andrea
Author Bertrand Fabre
Author Prisca Boisguerin
Author Sylvain de Rossi
Author Corinne Henriquet
Author Martine Pugnière
Author Manuelle Ducoux-Petit
Author Odile Burlet-Schiltz
Author Angus I. Lamond
Author Philippe Fort
Author Séverine Boulon
Author Marie-Pierre Bousquet
Author Olivier Coux
Abstract PA28? is a nuclear activator of the 20S proteasome involved in the regulation of several essential cellular processes, such as cell proliferation, apoptosis, nuclear dynamics, and cellular stress response. Unlike the 19S regulator of the proteasome, which specifically recognizes ubiquitylated proteins, PA28? promotes the degradation of several substrates by the proteasome in an ATP- and ubiquitin-independent manner. However, its exact mechanisms of action are unclear and likely involve additional partners that remain to be identified. Here we report the identification of a cofactor of PA28?, PIP30/FAM192A. PIP30 binds directly and specifically via its C-terminal end and in an interaction stabilized by casein kinase 2 phosphorylation to both free and 20S proteasome-associated PA28?. Its recruitment to proteasome-containing complexes depends on PA28? and its expression increases the association of PA28? with the 20S proteasome in cells. Further dissection of its possible roles shows that PIP30 alters PA28?-dependent activation of peptide degradation by the 20S proteasome in vitro and negatively controls in cells the presence of PA28? in Cajal bodies by inhibition of its association with the key Cajal body component coilin. Taken together, our data show that PIP30 deeply affects PA28? interactions with cellular proteins, including the 20S proteasome, demonstrating that it is an important regulator of PA28? in cells and thus a new player in the control of the multiple functions of the proteasome within the nucleus.
Publication Proceedings of the National Academy of Sciences of the United States of America
Volume 115
Issue 28
Pages E6477-E6486
Date 07 10, 2018
Journal Abbr Proc. Natl. Acad. Sci. U.S.A.
Language eng
DOI 10.1073/pnas.1722299115
ISSN 1091-6490
Library Catalog PubMed
Extra PMID: 29934401 PMCID: PMC6048556
Tags author, Autoantigens, Cajal bodies, Cell Nucleus, FAM192A, HeLa Cells, Humans, Nuclear Proteins, nuclear proteolysis, original, PA28?, pp2i, Proteasome Endopeptidase Complex, Protein Binding, Protein Domains, Proteins
Date Added 2019/06/04 - 17:21:00
Date Modified 2020/01/14 - 10:25:19


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés